Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Curtis, C. E. Articles by Iacono, W. G. Search for Related Content PubMed Citation Articles by Curtis, C. E. Articles by Iacono, W. G. Schizophrenia Spectrum Disorders Symptoms/Dimensions Genetics

Saccadic Disinhibition in Patients With Acute and Remitted Schizophrenia and Their First-Degree Biological Relatives

OBJECTIVE: Performance on measures of saccadic inhibition and control was investigated in a large family study of schizophrenia to evaluate the utility of using antisaccade task performance as an endophenotypic marker of genetic liability for schizophrenia. METHOD: Ninety-five patients with acute schizophrenia and 116 of their first-degree biological relatives, 13 schizophrenia patients whose illness was in full remission, 35 patients with acute psychotic affective disorder, and 109 nonpsychiatric comparison subjects were administered antisaccade and prosaccade tasks. RESULTS: Both schizophrenia patient groups had a greater number of errors on the antisaccade task than did the first-degree relatives and the affective disorder group, which both had more errors than the comparison subjects. Among the first-degree relatives of the probands with acute schizophrenia, relatives of poor-performing patients performed worse on the antisaccade task than relatives of patients with good performance. Reflexive errors were not likely the result of interfering psychotic symptoms, medication, or medication side effects. Although the schizophrenia patients demonstrated other signs of saccadic abnormalities, these problems, which were not observed in their relatives even though they had high antisaccade error rates, seem unlikely to account for the higher antisaccade error rate of the schizophrenia patients. CONCLUSIONS: These findings suggest that saccadic disinhibition is strongly associated with the genetic liability for schizophrenia.

This article has been cited by other articles:

				S. K. Hill, M. S. H. Harris, E. S. Herbener, M. Pavuluri, and J. A. Sweeney Neurocognitive Allied Phenotypes for Schizophrenia and Bipolar Disorder Schizophr Bull, July 1, 2008; 34(4): 743 - 759. [Abstract] [Full Text] [PDF]

				F. E. Polli, J. J. S. Barton, K. N. Thakkar, D. N. Greve, D. C. Goff, S. L. Rauch, and D. S. Manoach Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia Brain, April 1, 2008; 131(4): 971 - 986. [Abstract] [Full Text] [PDF]

				B. I. Turetsky, M. E. Calkins, G. A. Light, A. Olincy, A. D. Radant, and N. R. Swerdlow Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures Schizophr Bull, January 1, 2007; 33(1): 69 - 94. [Abstract] [Full Text] [PDF]

				B. E Snitz, A. W MacDonald III, and C. S Carter Cognitive Deficits in Unaffected First-Degree Relatives of Schizophrenia Patients: A Meta-analytic Review of Putative Endophenotypes Schizophr Bull, January 1, 2006; 32(1): 179 - 194. [Abstract] [Full Text] [PDF]

				N. C. Andreasen, W. T. Carpenter Jr., J. M. Kane, R. A. Lasser, S. R. Marder, and D. R. Weinberger Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus Am J Psychiatry, March 1, 2005; 162(3): 441 - 449. [Abstract] [Full Text] [PDF]

				S B Hutton Improved antisaccade performance in schizophrenia with risperidone J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 429 - 429. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us